https://bibbinstruments.com/en/bibb-receives-an-intention-to-grant-for-electric-driven-endodrill-in-europe/2023-12-20T18:06:12+01:00https://bibbinstruments.com/en/bibb-receives-another-intention-to-grant-notice-for-endodrill-in-europe/2023-12-20T18:05:55+01:00https://bibbinstruments.com/en/bibb-receives-market-clearance-for-endodrill-gi-in-the-us/2023-12-20T18:06:48+01:00https://bibbinstruments.com/en/bibb-informs-about-the-status-of-the-ce-marking-process-according-to-mdr/2023-12-20T18:04:40+01:00https://bibbinstruments.com/en/bibb-reports-positive-results-from-clinical-pilot-study-with-endodrill-uro/2023-12-20T18:03:36+01:00https://bibbinstruments.com/en/bibb-receives-approval-of-two-patents-in-europe-for-endodrill/2023-12-20T18:02:53+01:00https://bibbinstruments.com/en/first-us-clinical-cases-successfully-conducted-with-endodrill-gi/2024-02-06T16:02:39+01:00https://bibbinstruments.com/en/bibb-receives-european-ce-mark-approval-according-to-mdr-for-the-entire-endodrill-product-family/2024-02-07T11:44:36+01:00https://bibbinstruments.com/en/bibb-launches-new-website/2024-02-13T17:13:29+01:00https://bibbinstruments.com/en/uc-davis-health-reports-positive-clinical-experiences-with-endodrill-gi/2024-02-15T10:16:42+01:00https://bibbinstruments.com/en/japanese-patent-office-issues-decision-to-grant-patent-for-endodrill-technology/2024-02-21T16:17:25+01:00https://bibbinstruments.com/en/first-clinical-cases-with-endodrill-gi-successfully-performed-at-karolinska-university-hospital-in-sweden/2024-04-05T11:21:29+02:00https://bibbinstruments.com/en/successful-clinical-pilot-study-with-endodrill-gi-published-in-peer-reviewed-scientific-journal/2024-04-17T13:23:09+02:00https://bibbinstruments.com/en/bibb-receives-patent-approval-for-endodrill-in-india/2024-04-18T11:44:16+02:00https://bibbinstruments.com/en/endodrill-presented-as-new-kid-on-the-block-at-esge-days/2024-04-30T11:34:41+02:00https://bibbinstruments.com/en/successful-case-studies-with-endodrill-gi-continue-in-norway-and-sweden/2024-05-17T11:10:45+02:00https://bibbinstruments.com/en/bibbinstruments-ab-carries-out-a-directed-share-issue-of-sek-10-0-million/2024-05-20T16:26:08+02:00https://bibbinstruments.com/en/endodrill-is-recognized-as-a-promising-new-product-for-solving-a-significant-clinical-problem-in-a-medical-journal/2024-06-04T13:40:15+02:00https://bibbinstruments.com/en/successful-introduction-of-endodrill-gi-at-university-hospital-center-sestre-milosrdnice-in-zagreb-croatia/2024-09-02T11:22:30+02:00https://bibbinstruments.com/en/bibb-receives-an-intention-to-grant-for-endodrill-patent-in-europe/2024-11-20T17:42:47+01:00https://bibbinstruments.com/en/endodrill-gi-sparks-interest-at-the-7th-nordic-eus-meeting-in-copenhagen/2024-11-20T17:41:29+01:00https://bibbinstruments.com/en/new-peer-reviewed-clinical-case-series-in-the-u-s-shows-100-diagnostic-accuracy-with-endodrill-gi/2024-10-02T08:58:33+02:00https://bibbinstruments.com/en/bibb-receives-an-intention-to-grant-for-endodrill-patent-in-china/2024-11-20T17:45:23+01:00https://bibbinstruments.com/en/impressive-us-clinical-case-series-presented-at-acg-2024-in-philadelphia/2024-11-20T17:40:10+01:00https://bibbinstruments.com/en/bibb-has-initiated-a-collaboration-with-swedish-contract-manufacturer-cenova/2024-11-20T17:39:28+01:00https://bibbinstruments.com/en/well-executed-clinical-introduction-of-endodrill-gi-at-sahlgrenska-university-hospital-in-sweden/2024-11-20T17:38:46+01:00https://bibbinstruments.com/en/clinical-evaluation-at-karolinska-university-hospital-is-progressing/2024-11-25T11:39:46+01:00https://bibbinstruments.com/en/bibbinstruments-announces-preliminary-outcome-of-rights-issue/2025-01-21T18:19:29+01:00https://bibbinstruments.com/en/bibbinstruments-announces-final-outcome-of-rights-issue/2025-01-22T19:11:27+01:00https://bibbinstruments.com/en/bibb-receives-first-order-for-endodrill-gi-from-a-university-hospital-in-the-us/2025-01-24T14:17:56+01:00https://bibbinstruments.com/en/bibb-participated-in-clinical-cases-with-endodrill-gi-in-germany-for-the-indication-eus-guided-liver-biopsy/2025-02-12T11:22:51+01:00https://bibbinstruments.com/en/first-liver-cases-with-endodrill-gi-performed-in-the-usa/2025-02-21T09:16:42+01:00https://bibbinstruments.com/en/successful-live-broadcasted-patient-case-with-endodrill-gi-in-porto-portugal/2025-03-18T09:09:44+01:00https://bibbinstruments.com/en/bibb-receives-notice-of-allowance-for-additional-endodrill-patent-in-china/2025-04-07T13:01:42+02:00https://bibbinstruments.com/en/bibb-and-taewoong-medical-usa-sign-letter-of-intent-for-u-s-commercialization-of-endodrill-gi/2025-05-02T18:02:13+02:00https://bibbinstruments.com/en/bibb-receives-u-s-patent-notice-of-allowance-for-endodrill/2025-05-15T12:15:50+02:00https://bibbinstruments.com/en/bibbinstruments-ab-the-subscription-price-for-warrants-of-series-to-1-set-at-sek-3-25-per-share/2025-05-19T11:05:15+02:00https://bibbinstruments.com/en/bibbinstruments-ab-the-subscription-period-for-warrants-of-series-to-1-begins-today/2025-05-21T16:28:43+02:00https://bibbinstruments.com/en/bibbinstruments-ab-publishes-a-letter-from-ceo-fredrik-lindblad/2025-05-21T16:36:46+02:00https://bibbinstruments.com/en/bibbinstruments-ab-receives-intention-of-subscription-regarding-warrants-of-series-to-1-from-management-and-board-members/2025-05-29T21:16:13+02:00https://bibbinstruments.com/en/bibbinstruments-ab-announces-outcome-of-subscription-period-for-warrants-of-series-to-1/2025-06-09T16:21:16+02:00https://bibbinstruments.com/en/bibbinstruments-announces-date-for-conversion-of-exercised-warrants-of-series-to-1-into-shares/2025-06-18T14:10:49+02:00https://bibbinstruments.com/en/decision-to-grant-third-endodrill-patent-in-japan/2025-06-24T13:17:46+02:00https://bibbinstruments.com/en/bibb-signs-exclusive-distribution-agreement-with-taewoong-medical-usa/2025-08-04T11:42:47+02:00https://bibbinstruments.com/en/henry-ford-st-john-hospital-reports-first-u-s-liver-biopsy-cases-with-endodrill-gi/2025-08-11T09:53:23+02:00https://bibbinstruments.com/en/bibb-engages-eus-pioneer-professor-peter-vilmann-as-scientific-advisor/2025-09-04T10:06:16+02:00https://bibbinstruments.com/en/initial-results-from-mayo-clinic-indicate-potential-of-endodrill-gi-in-tissue-culture-based-pancreatic-cancer-research/2025-09-09T11:39:49+02:00https://bibbinstruments.com/en/endodrill-gi-has-officially-launched-in-the-united-states/2025-10-28T08:13:08+01:00https://bibbinstruments.com/en/u-s-tour-fall-2025-bibb-strengthens-its-presence-in-the-american-market/2025-12-03T16:12:03+01:00https://bibbinstruments.com/en/bibbinstruments-receives-additional-orders-for-endodrill-gi-from-the-u-s/2025-12-17T11:39:15+01:00https://bibbinstruments.com/en/bibbinstruments-announces-the-board-of-directors-intention-to-resolve-on-a-rights-issue-of-approximately-sek-60-million/2026-02-09T19:16:55+01:00https://bibbinstruments.com/en/notice-of-extraordinary-general-meeting-of-bibbinstruments-ab-publ/2026-02-10T16:59:39+01:00https://bibbinstruments.com/en/communique-from-the-extraordinary-general-meeting-in-bibbinstruments-ab-held-on-13-march-2026/2026-03-13T16:22:30+01:00https://bibbinstruments.com/en/bibbinstruments-resolves-on-the-previously-announced-rights-issue-of-approximately-sek-60-3-million/2026-03-19T14:47:15+01:00https://bibbinstruments.com/en/bibbinstruments-ab-publ-publishes-information-document-in-connection-with-rights-issue/2026-03-24T17:44:54+01:00https://bibbinstruments.com/en/correction-bibbinstruments-ab-publ-publishes-updated-information-document-in-connection-with-rights-issue-incorrect-isin-code-for-the-share/2026-03-25T22:05:00+01:00https://bibbinstruments.com/en/bibbinstruments-receives-additional-subscription-intentions-in-the-ongoing-rights-issue/2026-04-01T11:32:44+02:00https://bibbinstruments.com/en/bibbinstruments-announces-outcome-in-rights-issue/2026-04-15T14:23:27+02:00https://bibbinstruments.com/en/shareholding-notification-in-bibbinstruments-ab-publ/2026-04-17T15:19:56+02:00